Tet1-dCas9 Citations (1)

Originally described in: Aberrant promoter methylation contributes to LRIG1 silencing in basal/triple-negative breast cancer.
Umeh-Garcia M, O'Geen H, Simion C, Gephart MH, Segal DJ, Sweeney CA Br J Cancer. 2022 Apr 19. pii: 10.1038/s41416-022-01812-8. doi: 10.1038/s41416-022-01812-8. PubMed Journal

---

Articles Citing Tet1-dCas9

Articles
Defining Mechanistic Links Between the Non-Coding Variant rs17673553 in CLEC16A and Lupus Susceptibility. Rallabandi HR, Singh MK, Looger LL, Nath SK. Int J Mol Sci. 2025 Jan 1;26(1):314. doi: 10.3390/ijms26010314. PubMed

If you have published an article using this material, please email us at to have your article added to this page.